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stimulant ADHD 22 
nonstimulant ADHD 9 
other psychotropic medication 7 
more than one medication 9 
no medication 9 
Supplemental Table 1. Psychotropic medication usage in the ADHD diagnosed (N=35) sample. Medications are 
listed for any individual who reported currently taking psychotropic medication (N=26). Of note, some medicated 
participants reported not taking medication on the day of scanning (N=13 of 35 reported use of psychotropic 
medication on the day of the scan session). Nine children diagnosed with ADHD were completely medication-free. 
Nine children were on more than one medication (reported within stimulant and nonstimulant totals above; five were 
on a combination of ADHD medications and four were on a combination of ADHD and other psychotropic 
medications). Non-diagnosed participants (N=28) were not on any psychotropic medications.  
Stimulant ADHD medications included Adderall, Concerta, Daytrana, Focalin, and Ritalin. 
Non-stimulant ADHD medications included Vayrin, Intuniv, Strattera, and Clonidine. 
Other psychotropic medication included selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake 






Additional Diagnosis N 
Anxiety 2 
Dyslexia 4 
Autism Spectrum Disorder 2 
Tourette Syndrome 2 
Bipolar Disorder 1 
Obsessive Compulsive Disorder 1 
Supplemental Table 2. Comorbid disorders with ADHD in the ADHD-diagnosed sample (N =35). Ten children had 











Supplemental Figure 1. Frames scrubbed from each task. Percent of total frames collected 
censored at FD > 0.9 mm plotted for each individual by diagnostic group. Errors bars represent 
standard deviation from the mean. Plots reflect all collected data for the analyzed sample (N=63) 
before any runs were dropped (for high overall motion, poor task performance, or preprocessing 
problems - see main text for run exclusions). There were no significant group differences in % 















Supplemental Figure 2. Behavioral performance for each task. a. Accuracy on the three tasks 
plotted for each individual by group; b. Response time for the three tasks plotted for each 
individual by group; Errors bars represent standard deviation from the mean; SSRT group means 
are different at p < .05 (*);  Plots reflect all collected data for the full sample (N=63) before 













Common EF activity across tasks 
Methods for creating maps of common EF activity across tasks were closely modeled 
after previous work with the same tasks (Engelhardt et al., 2019). The samples (n=117, 
Engelhardt et al., and n =63, current sample) overlapped by 1 person. A difference from the 
analysis of Engelhardt and colleagues, which examined overlap across correct trials only, was 
that this analysis examined activity across all trials. One contrast from each task (cue vs. baseline 
from the cognitive flexibility task, 2-back block vs. baseline from the N-back task and stop vs. 
baseline from the SST) was used to test for common EF activity across domains (following 
Engelhardt et al., 2019). Contrasts were thresholded at Z  > 3.1 and p < .05 (Supplemental Figure 
3). 
 
Supplemental Figure 3. Main effect contrasts of interest from three EF tasks across the whole 
sample (N= 62 for the cognitive flexibility task, N = 60 for the working memory task, N = 53 for 
the inhibition task). a. cue vs. baseline from the cognitive flexibility task b. target vs. baseline 
from the cognitive flexibility task c. whole trial vs. baseline from the cognitive flexibility task d. 




Maps of positive tasks activity (activity greater than baseline) were then binarized. The 
three binarized maps from each task were overlaid to create one map of overlapping and unique 
task activity. To measure the distances between the ROIs from the previous study (Engelhardt et 
al., 2019) and our clusters of overlapping activity across the three tasks FSL Cluster tool was 
used to identify coordinates for the center of each cluster within the summed task-overlap mask. 
The distance between ROIs from the previous study and the center of clusters from the current 
study was computed as: 
 distance (mm) = !(𝑥$ − 𝑥&)( + (𝑦$ − 𝑦&)( + (𝑧$ − 𝑧&)( 
where x, y, and z correspond to the MNI coordinates for the current study’s centers of activity 
(A) and previously seen pediatric ROIs (Engelhardt et al., 2019) (B). 
Core EF regions of interest (ROI) analysis 
To test for relations between ADHD symptom burden and brain activity in core EF regions, 
the 11 ROIs from the previous study (Engelhardt et al., 2019) that captured the core EF activity 
in an independent pediatric sample were used in an applied ROI analysis (see Study 1, Table 2 
for ROIs and coordinates). ROI analyses were carried out using FSL and R. The 11 sets of 
coordinates were used to create 5 mm radius ROIs using the T1 MNI152 2mm mask in FSL. To 
test for relations between brain activity in these ROIs and symptom burden, ROIs were applied 
to the BOLD activity of each of the three EF tasks. Neural activity parameter estimates for each 
contrast were calculated for each ROI, for each individual. One sample two-tailed t-tests were 
used to assess whether ROIs had a mean activity across individuals that was significantly 
different from 0. Semipartial correlations controlling for age were estimated between parameter 
estimates from the ROIs and raw inattention and hyperactivity PCR scores.  
 6 
 
Restricted comorbidity and medication subgroup analysis 
 To examine potential influence of comorbid diagnoses and medication use, all of the same 
whole-brain symptom burden correlation models described in Materials & Methods were run 
with all typically developing participants and a restricted subset of individuals who had an 
ADHD diagnosis but no comorbid diagnoses and were psychotropic medication-free at time of 
scan (N=45 across the whole group, N= 44 for the cognitive flexibility task, N = 42 for the 
working memory task, N =39 for the inhibition task). Mean centered age was included as a 
covariate of no interest in all models. 
 
Supplemental Results 
Core EF regions of interest (ROI) ADHD symptom analysis 
First, we tested that there was significant engagement of the applied regions in the 
contrasts. Seven of the 11 applied ROIs had mean activity > 0 during the target period of the 
cognitive flexibility task (all but the right middle frontal gyrus, right anterior insula, right dorsal 
lateral prefrontal cortex, and right inferior parietal ROIs). Ten of the 11 had mean activity > 0 
during the cue period of the cognitive flexibility task (all but the right inferior parietal lobe ROI). 
All 11 of ROIs had mean activity > 0 during the working memory task. Ten of the 11 had mean 
activity > 0 during the inhibition task (all but the right frontal eye field ROI). All p’s < .05 
corrected for multiple comparisons.  
Before correction for multiple comparisons, during the target period of the cognitive 
flexibility task, the frontal eye field (r = .28, p = .03) showed a positive relation to hyperactivity 
symptom burden. There were no relations to inattention symptom burden. There were no 
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relations between either inattention or hyperactivity ADHD symptom burden and the ROIs 
during the cue period or whole trial of the cognitive flexibility task (all p’s > .1). During the 
working memory task hyperactivity was negatively related to the left inferior parietal lobe (r = -
.26, p = .05). All reported values are uncorrected for multiple comparisons, and these effects did 
not survive FDR multiple comparison correction. There were no relations to inattention 
symptoms (lowest p = .08 uncorrected). No relation was seen for any ROIs during the inhibition 




Restricted comorbidity and medication subgroup analysis 
Restricted comorbidity and medication use subgroup whole brain analyses 
 Fewer effects were observed in the restricted (no comorbidities, no medication) subgroup 
analysis, likely due to the smaller size of the groups (Supplemental Figure 4; Supplemental Table 
3). Importantly, removing medication use and comorbidities did not make any task-ADHD 
relations more similar to each other across different tasks. During the cognitive flexibility task 
(whole trial vs. baseline) there was a negative relationship between inattention and neural 
activity in a region spanning the right orbital frontal cortex and right anterior insula, as well as a 
region of the dorsal-lateral prefrontal cortex During the working memory task, there was a 
positive correlation between hyperactivity and neural activity in a similar region of medial 
prefrontal cortex to the models with the full group and a novel region in the lateral left anterior 
prefrontal cortex. Also, in the working memory task, there was a positive correlation between 
inattention symptoms and neural activity in the right frontal pole. There was no relation between 




Supplemental Figure 4. Whole brain restricted comorbidity and medication subgroup analysis: 
Parent-rated inattention and hyperactivity symptom burdens correlated with neural activity 
across the EF tasks. Whole brain images and parameter estimates (PE) of brain activity plotted 
with mean-centered measures of symptom burden, controlling for age, from the whole-brain 
correlational models. a. Correlation between inattention symptom burden and the cognitive 
flexibility task (whole trial vs. baseline) resulted in a right OFC region; b. Correlation between 
hyperactivity and inattention symptom burden during the working memory task (2back vs, 
baseline) resulted in mPFC regions. No significant results were found in the inhibition task. 
Scatterplots merely depict whole brain correlations; no additional statistical tests were run on 









Correlation Brain area Peak Coordinates No. of 
voxels 
    x y z  
CF 
 
inattention negative right ventral frontal 
cortex/inferior insula  
+40 +26 -20 101 
right anterior prefrontal 
cortex 





medial prefrontal cortex +8 +32 -2 339 
left anterior prefrontal 
cortex 
-22 +40 +50 83 
right orbital frontal cortex +28 +34 -2 83 
inattention positive right ventral medial 
prefrontal cortex/orbital 
frontal cortex 
+24 +30 -4 127 
        
Supplemental Table 3. Peak coordinates and cluster size from symptom burden correlations in 
restricted subgroup (N=44 for the cognitive flexibility task, N = 42 for the working memory task) 
whole brain analysis. CF = cognitive flexibility (whole trial vs. baseline); WM = working 
memory (2back vs. baseline); age was included in the covariate models; maps were cluster 
corrected for multiple comparisons z > 3.1 p <.05; coordinates are reported in standard MNI 
space 
 
Restricted comorbidity and medication use subgroup ROI analyses 
The same significant main effect engagement of applied ROIs was seen in the restricted 
subgroup as in the larger group above. Before correction for multiple comparisons, three ROIs 
showed correlations to hyperactivity symptom burden across the task contrasts. During the target 
period of the cognitive flexibility task, the left frontal eye field (r = .37, p = .01) and the left 
insula (r = .39, p = .009) were related to hyperactivity, while during the working memory task 
the right middle frontal gyrus was negatively related to inattention  (r = - .35, p = .02). There was 
no relation between the ROIs during any task and inattention symptom burden. Just as in the 
larger group, the symptom profile effects were not consistent across EF domains and did not 
survive correction for multiple comparisons.   
 
 
